New mesh aims to improve breast reconstruction outcomes
Disease control
Not yet recruiting
This study will test the safety and effectiveness of a product called OviTex PRS in women having breast reconstruction with implants after mastectomy (breast removal for cancer or prevention). About 235 women aged 22-75 who are non-smokers and having immediate reconstruction will…
Phase: NA • Sponsor: Tela Bio Inc • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC